National Advisory Committee on Immunization (NACI). Statement on thimerosal.
Gemmill
Ian
I
D002170:Canada; D002626:Chemistry, Pharmaceutical; D004342:Drug Hypersensitivity; D006801:Humans; D007223:Infant; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects / Q000378:metabolism*; D013849:Thimerosal / Q000009:adverse effects / Q000378:metabolism*; D014612:Vaccines
D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal